Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2018 Jan 1;41(1):zsx190.
doi: 10.1093/sleep/zsx190.

Effects of Pharmacologic and Nonpharmacologic Interventions on Insomnia Symptoms and Self-reported Sleep Quality in Women With Hot Flashes: A Pooled Analysis of Individual Participant Data From Four MsFLASH Trials

Katherine A Guthrie  1 , Joseph C Larson  1 , Kristine E Ensrud  2 , Garnet L Anderson  1 , Janet S Carpenter  3 , Ellen W Freeman  4 , Hadine Joffe  5   6 , Andrea Z LaCroix  7 , JoAnn E Manson  6 , Charles M Morin  8 , Katherine M Newton  9 , Julie Otte  3 , Susan D Reed  10 , Susan M McCurry  11
Affiliations
Randomized Controlled Trial

Effects of Pharmacologic and Nonpharmacologic Interventions on Insomnia Symptoms and Self-reported Sleep Quality in Women With Hot Flashes: A Pooled Analysis of Individual Participant Data From Four MsFLASH Trials

Katherine A Guthrie et al. Sleep. .

Abstract

Study objectives: The Menopause Strategies: Finding Lasting Answers for Symptoms and Health network conducted three randomized clinical trials (RCTs) testing six interventions treating vasomotor symptoms (VMS), and also collected self-reported sleep outcomes. A fourth RCT assessed an intervention for insomnia symptoms among women with VMS. We describe these seven interventions' effects relative to control in women with comparably severe insomnia symptoms and VMS.

Methods: We analyzed pooled individual-level data from 546 peri- and postmenopausal women with Insomnia Severity Index (ISI) ≥ 12, and ≥14 bothersome VMS/week across the four RCTs. Interventions included the following: escitalopram 10-20 mg/day; yoga; aerobic exercise; 1.8 g/day omega-3 fatty acids; oral 17-beta-estradiol 0.5-mg/day; venlafaxine XR 75-mg/day; and cognitive behavioral therapy for insomnia (CBT-I). Outcome measures were ISI and Pittsburgh Sleep Quality Index (PSQI) over 8-12 weeks of treatment.

Results: CBT-I produced the greatest reduction in ISI from baseline relative to control at -5.2 points (95% CI -7.0 to -3.4). Effects on ISI were similar for exercise at -2.1 and venlafaxine at -2.3 points. Comparably small decreases in ISI were observed with escitalopram, yoga, and estradiol. The largest reduction in PSQI from baseline was with CBT-I at -2.7 points (-3.9 to -1.5), although PSQI decreases of 1.2 to 1.6 points were significantly better than control with escitalopram, exercise, yoga, estradiol, and venlafaxine. Omega-3 supplements did not improve insomnia symptoms.

Conclusions: This study's findings support current recommendations for CBT-I as a first line treatment in healthy midlife women with insomnia symptoms and moderately bothersome VMS.

Trial registration: ClinicalTrials.gov NCT00894543 NCT01178892 NCT01418209 NCT01936441.

Keywords: insomnia; menopause; vasomotor symptoms.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Mean effect (95% confidence interval) of each intervention relative to control on changes from baseline in ISI, N = 511. CBT-I = cognitive behavioral therapy for insomnia; ISI = Insomnia Severity Index.
Figure 2
Figure 2
Mean effect (95% confidence interval) of each intervention relative to control on changes from baseline in PSQI, N = 494. CBT-I = cognitive behavioral therapy for insomnia; PSQI = Pittsburgh Sleep Quality Index.
Figure 3
Figure 3
Odds ratio (95% confidence interval) of insomnia symptoms remission (ISI < 8) relative to control at end of treatment by intervention, N = 503. CBT-I = cognitive behavioral therapy for insomnia; ISI = Insomnia Severity Index.
See this image and copyright information in PMC

References

    1. Shaver JL, Woods NF. Sleep and menopause: a narrative review. Menopause. 2015; 22(8): 899–915. - PubMed
    1. Xu Q, Lang CP. Examining the relationship between subjective sleep disturbance and menopause: a systematic review and meta-analysis. Menopause. 2014; 21(12): 1301–1318. - PubMed
    1. Kravitz HM, Joffe H. Sleep during the perimenopause: a SWAN story. Obstet Gynecol Clin North Am. 2011; 38(3): 567–586. - PMC - PubMed
    1. Freedman RR. Pathophysiology and treatment of menopausal hot flashes. Semin Reprod Med. 2005; 23(2): 117–125. - PubMed
    1. Freeman EW, Sammel MD, Gross SA, Pien GW. Poor sleep in relation to natural menopause: a population-based 14-year follow-up of midlife women. Menopause. 2015; 22(7): 719–726. - PMC - PubMed

Publication types

MeSH terms

Associated data